Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug approvals
Pharma
Regulatory tracker: AZ continues Breztri's asthma expansion
Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
Angus Liu
,
Kevin Dunleavy
,
Fraiser Kansteiner
,
Donavyn Coffey
Sep 24, 2026 10:00am
FDA's surprise approval of AZ's oral SERD sets new paradigm
Sep 8, 2026 10:35am
FDA docs shed light on contentious nod for Replimune's Trudiqev
Sep 3, 2026 12:10pm
Roche-Hanmi, Akeso, a congressman's concerns—Fierce Pharma Asia
Aug 28, 2026 9:00am
Priovant secures 1st FDA nod in rare skin and muscle disease
Aug 27, 2026 9:30pm
FDA approves Otsuka’s first-in-class ADHD drug Simtriyo
Jul 27, 2026 12:42pm